Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable
Author:
Affiliation:
1. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California
2. Department of Radiation Oncology, University of Michigan, Ann Arbor
3. NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770281/zumsteg_2020_ld_200106_1602712461.33958.pdf
Reference6 articles.
1. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.;Zumsteg;Eur Urol,2013
2. Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.;Keane;Cancer,2015
3. Radiotherapy and short-term androgen deprivation for localized prostate cancer.;Jones;N Engl J Med,2011
4. Comparison of treatment effects measured by the hazard ratio and by the ratio of restricted mean survival times in oncology randomized controlled trials.;Trinquart;J Clin Oncol,2016
5. The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease.;Keane;Cancer,2014
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer;Cureus;2024-03-07
2. Re: Dose-escalated Radiotherapy Alone or in Combination with Short-term Androgen Deprivation for Intermediate-risk Prostate Cancer: Results of a Phase III Multi-institutional Trial;European Urology;2023-12
3. The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography;Communications Medicine;2023-11-09
4. Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer;European Urology Oncology;2023-11
5. Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer;Prostate International;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3